Zacks Research Cuts Earnings Estimates for Core Laboratories

Core Laboratories Inc. (NYSE:CLB) – Investment analysts at Zacks Research decreased their Q3 2027 earnings estimates for Core Laboratories in a report issued on Thursday, April 23rd. Zacks Research analyst Team now forecasts that the oil and gas company will post earnings of $0.27 per share for the quarter, down from their previous estimate of $0.32. The consensus estimate for Core Laboratories’ current full-year earnings is $0.57 per share. Zacks Research also issued estimates for Core Laboratories’ FY2027 earnings at $1.06 EPS.

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a report on Friday, March 27th. Four analysts have rated the stock with a Hold rating, According to MarketBeat, Core Laboratories currently has an average rating of “Hold” and a consensus target price of $12.50.

Core Laboratories Stock Up 0.0%

Shares of Core Laboratories stock opened at $17.06 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.02 and a quick ratio of 1.51. Core Laboratories has a 1 year low of $9.72 and a 1 year high of $20.36. The firm’s 50-day moving average is $16.85 and its two-hundred day moving average is $16.50. The stock has a market cap of $785.75 million, a price-to-earnings ratio of 25.47, a PEG ratio of 3.21 and a beta of 1.15.

Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The business had revenue of $138.26 million during the quarter, compared to analyst estimates of $130.40 million. Core Laboratories had a return on equity of 12.18% and a net margin of 6.04%.Core Laboratories’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.22 EPS. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were issued a dividend of $0.01 per share. The ex-dividend date was Friday, February 13th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Core Laboratories’s dividend payout ratio is 5.97%.

Hedge Funds Weigh In On Core Laboratories

Several hedge funds have recently modified their holdings of the stock. CWM LLC increased its holdings in shares of Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after acquiring an additional 668 shares in the last quarter. Platinum Investment Management Ltd. increased its holdings in shares of Core Laboratories by 3.9% during the third quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock valued at $294,000 after acquiring an additional 889 shares in the last quarter. Illinois Municipal Retirement Fund increased its holdings in shares of Core Laboratories by 4.0% during the third quarter. Illinois Municipal Retirement Fund now owns 23,366 shares of the oil and gas company’s stock valued at $289,000 after acquiring an additional 898 shares in the last quarter. Advisors Capital Management LLC lifted its stake in shares of Core Laboratories by 0.3% during the third quarter. Advisors Capital Management LLC now owns 275,975 shares of the oil and gas company’s stock worth $3,411,000 after buying an additional 912 shares during the period. Finally, Fox Run Management L.L.C. lifted its stake in shares of Core Laboratories by 5.9% during the third quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock worth $229,000 after buying an additional 1,038 shares during the period. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.